Novartis et al. in $36m series-B for GenSight
Novartis Venture Fund, Abingworth, Versant Ventures and Index Ventures have taken part in a $36m series-B round for French biotech GenSight Biologics after supporting a €32m series-A financing in 2013.
More on France
Naxicap to exit ECF in SBO to PAI
Hospitality and care equipment producer marks fifth deal from PAI’s eighth flagship fund
Cerea Partners raises EUR 700m-plus for multi-asset food and beverage funds
France-headquartered GP is on the road for vehicles across its private equity, mezzanine and senior debt strategies
Montagu exits Maincare to state-owned Docaposte in off-market deal
Hospital software group considered "missing piece" in buyer's healthcare digitalisation strategy
Mircap nears first close for debut co-investment fund
GP led by Michele Mezzarobba and François Pinel de Golleville will aim to raise EUR 100-120m
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Czech Republic-headquartered family office is targeting DACH and CEE region deals
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds